[1]Anversa P, Kajstura J, Leri A, et al. Life and death of cardiac stem cells: a paradigm shift in cardiac biology[J]. Circulation, 2006,113(11):1451-1463.
[2]Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction[J]. N Engl J Med, 2001,344(23):1750-1757.
[3]Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration[J]. Cell, 2003,114(6):763-776.
[4]Tang XL, Rokosh G, Sanganalmath SK, et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction[J]. Circulation, 2010, 121(2):293-305.
[5]Rota M, Padin-Iruegas ME, Misao Y, et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function[J]. Circ Res, 2008, 103(1): 107-116.
[6]Faulx MD, Ernsberger P, Vatner D, et al. Strain-dependent-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice[J]. Am J Physiol Heart Circ Physiol, 2005, 289(1): H30-H36.
[7]Boluyt MO, Long X, Eschenhagen T, et al. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart[J]. Am J Physi, 1995, 269(2Pt2): H638-647.
[8]Brooks WW, Conrad CH. Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates[J]. Comp Med, 2009, 59(4): 339-343.[9]Marques FD, Ferreira AJ, Sinisterra RD, et al. An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats[J]. Hypertension, 2011, 57(3):477-483.
[10]Teerlink JR, Pfeffer JM, Pfeffer MA. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats[J]. Circ Res, 1994, 75(1):105-113.
[11]Benjamin IJ, Jalil JE, Tan LB, et al. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis[J]. Circ Res, 1989, 65(3):657-670.
[12]Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells[J]. Proc Natl Acad Sci USA, 2007, 104(35):14068-14073.
[13]Rupp S, Bauer J, von Gerlach S, et al. Pressure overload leads to an increase of cardiac resident stem cells[J]. Basic Res Cardiol, 2012, 107(2): 252.
[14]Li N, Pasha Z, Ashraf M. Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factors[J]. PLoS One, 2014, 9(4):e93645.
[15]Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and muring heart[J]. Circ Res, 2004, 95(9):911-921.
[16]Martin CM, Meeson AP, Robertson SM, et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identified cardiac SP cells in the developing and adult heart[J]. Dev Biol, 2004, 265(1):262-275.
[17]Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation and fusion after infarction[J]. Proc Nati Acad Sci, 2003, 100(21):12313-12318.
[18]Riekstina U, Cakstina I, Parfejevs V, et al. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis[J]. Stem Cell Rev, 2009, 5(4): 378-386.
[19]Zhang S, Ma X, Yao K, et al. Combination of CD34-positive cell subsets with infarcted myocardium-like matrix stiffness: a potential solution to cell-based cardiac repair[J]. J Cell Mol Med, 2014,18(6):1236-1238.
[20]Mitsui K, Tokuzawa Y, Itoh H, et al. The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells[J]. Cell, 2003, 113(5):631-642.
[21]Li TS, Cheng K, Lee ST, et al. Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair[J]. Stem Cells, 2010, 28(11): 2088-2098.
[22]Bellafiore M, Sivverini G, Cappello F, et al. Research of cardiomyocyte precursors in adult rat heart[J]. Tissue Cell, 2006, 38(6):345-351.
[23]Abdel-Latif A, Zuba-Surma EK, Ziada KM, et al. Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia[J]. Exp Hematol, 2010, 38(12):1131-1142.
[24]Wojakowski W, Kucia M, Liu R, et al. Circulating very small embryonic-like stem cells in cardiovascular disease[J]. J Cardiovasc Transl Res, 2011, 4(2):138-144.
[25]Angert D, Berretta RM, Kubo H, et al. Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells[J]. Circ Res, 2011,108(10): 1226-1237.
[26]Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival[J]. Circ Res, 2005, 97(7):663-673. |